BG40142A3 - Method for preparing piperazine derivatives - Google Patents

Method for preparing piperazine derivatives

Info

Publication number
BG40142A3
BG40142A3 BG8257771A BG5777182A BG40142A3 BG 40142 A3 BG40142 A3 BG 40142A3 BG 8257771 A BG8257771 A BG 8257771A BG 5777182 A BG5777182 A BG 5777182A BG 40142 A3 BG40142 A3 BG 40142A3
Authority
BG
Bulgaria
Prior art keywords
piperazine derivatives
preparing piperazine
preparing
parenterally
physiologically
Prior art date
Application number
BG8257771A
Other languages
English (en)
Inventor
Beyerle
Bender
Schindler
Nitz
Martorana
Original Assignee
Cassella Ag,De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Ag,De filed Critical Cassella Ag,De
Publication of BG40142A3 publication Critical patent/BG40142A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG8257771A 1981-08-20 1982-08-18 Method for preparing piperazine derivatives BG40142A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813132882 DE3132882A1 (de) 1981-08-20 1981-08-20 Neue piperazinone, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
BG40142A3 true BG40142A3 (en) 1986-10-15

Family

ID=6139695

Family Applications (1)

Application Number Title Priority Date Filing Date
BG8257771A BG40142A3 (en) 1981-08-20 1982-08-18 Method for preparing piperazine derivatives

Country Status (23)

Country Link
US (1) US4598079A (fi)
EP (1) EP0072932B1 (fi)
JP (1) JPS5839673A (fi)
KR (1) KR880001622B1 (fi)
AT (1) ATE49596T1 (fi)
AU (1) AU556064B2 (fi)
BG (1) BG40142A3 (fi)
CA (1) CA1190227A (fi)
DD (1) DD206991A5 (fi)
DE (2) DE3132882A1 (fi)
DK (1) DK154765C (fi)
ES (1) ES8305739A1 (fi)
FI (1) FI76325C (fi)
GR (1) GR78362B (fi)
HU (1) HU190696B (fi)
IL (1) IL66566A (fi)
NO (1) NO822643L (fi)
NZ (1) NZ200761A (fi)
PH (1) PH18447A (fi)
PL (1) PL139405B1 (fi)
PT (1) PT75444B (fi)
RO (1) RO85267B (fi)
ZA (1) ZA826031B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772705A (en) * 1985-07-25 1988-09-20 Pennwalt Corporation Processes for the preparation of trans 1,3,4,6,7,11b-hexahydro-7-aryl-2H-pyrazinol[2,1-a]isoquinolines
JPS62198671A (ja) * 1986-02-25 1987-09-02 Toyo Jozo Co Ltd 1−置換アルキル1,2−ジヒドロ−2−ピラジノン誘導体
DE3817198A1 (de) * 1988-05-20 1989-11-30 Cassella Ag Thienyl-piperazinone, ihre herstellung und verwendung
US5238938A (en) * 1989-02-10 1993-08-24 Otsuka Pharmaceutical Co., Ltd. Indole derivatives
DE69029231T2 (de) * 1989-02-10 1997-03-20 Otsuka Pharma Co Ltd Indolderivate, ihre herstellung und diese enthaltendes arzneimittel zum verhindern und behandeln von nephritis
DE3908547A1 (de) * 1989-03-16 1990-09-20 Cassella Ag Thienylessigsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie diese enthaltende arzneimittel und deren herstellung
DE3909379A1 (de) * 1989-03-22 1990-09-27 Cassella Ag Thienylpiperazine, verfahren zu ihrer herstellung, ihre verwendung sowie diese enthaltende arzneimittel und deren herstellung
US5635510A (en) * 1993-05-06 1997-06-03 Merrell Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
DE4408530A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag Verfahren zur Herstellung von Aminoethylglycin
ES2132709T3 (es) 1994-08-25 1999-08-16 Merrell Pharma Inc Nuevas piperidinas substituidas utiles para el tratamiento de las enfermedades alergicas.
WO1996028441A1 (en) * 1995-03-15 1996-09-19 Hoechst Marion Roussel, Inc. Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists
NZ306022A (en) * 1995-04-13 1998-09-24 Hoechst Marion Roussel Inc Phenyl, naphthyl or indolyl substituted piperazine derivatives and medicaments
GB9510600D0 (en) * 1995-05-25 1995-07-19 Fujisawa Pharmaceutical Co Piperazine derivatives
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
CA2250587A1 (en) * 1996-04-03 1997-10-09 Christopher J. Dinsmore Inhibitors of farnesyl-protein transferase
SE9603283D0 (sv) * 1996-09-10 1996-09-10 Astra Ab New compounds
TW472045B (en) * 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
AR017200A1 (es) 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos
SE9800835D0 (sv) 1998-03-13 1998-03-13 Astra Ab New Compounds
US6492406B1 (en) 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
IN190478B (fi) * 2000-11-07 2003-08-02 Sun Pharmaceutical Ind Ltd
US6974869B2 (en) * 2001-09-18 2005-12-13 Bristol-Myers Squibb Pharma Company Piperizinones as modulators of chemokine receptor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1197089B (de) * 1962-01-25 1965-07-22 Richardson Merrell Inc Verfahren zur Herstellung von 2-Oxo-1, 2, 5, 6-tetrahydropyrazinen
US3390139A (en) * 1964-03-04 1966-03-11 Rohm & Haas Nu-vinyl-2-piperazinones
US3935214A (en) * 1968-07-26 1976-01-27 Donau-Pharmazie Gesellschaft M.B.H. 2-or 3 keto-3-or-2-phenyl-1,4-disubstituted piperazines
DE2438619A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Verfahren zur herstellung von substituierten 2-ketopiperazin-derivaten
AT356122B (de) * 1978-10-17 1980-04-10 Yoshitomi Pharmaceutical Verfahren zur herstellung von neuen pyridazinonderivaten und ihren salzen mit saeuren

Also Published As

Publication number Publication date
DE3132882A1 (de) 1983-03-03
FI822698L (fi) 1983-02-21
PH18447A (en) 1985-07-08
ES515120A0 (es) 1983-05-01
NZ200761A (en) 1985-04-30
JPS5839673A (ja) 1983-03-08
EP0072932A2 (de) 1983-03-02
US4598079A (en) 1986-07-01
DK342382A (da) 1983-02-21
PT75444B (de) 1985-01-04
FI822698A0 (fi) 1982-08-02
PT75444A (de) 1982-09-01
FI76325C (fi) 1988-10-10
ES8305739A1 (es) 1983-05-01
DD206991A5 (de) 1984-02-15
PL139405B1 (en) 1987-01-31
CA1190227A (en) 1985-07-09
AU556064B2 (en) 1986-10-23
ATE49596T1 (de) 1990-02-15
KR880001622B1 (ko) 1988-09-02
ZA826031B (en) 1983-07-27
KR840001158A (ko) 1984-03-28
EP0072932A3 (en) 1984-03-21
DK154765B (da) 1988-12-19
EP0072932B1 (de) 1990-01-17
RO85267B (ro) 1984-10-30
GR78362B (fi) 1984-09-26
RO85267A (ro) 1984-09-29
IL66566A (en) 1985-12-31
HU190696B (en) 1986-10-28
DK154765C (da) 1989-05-16
PL237952A1 (en) 1983-03-14
NO822643L (no) 1983-02-21
FI76325B (fi) 1988-06-30
DE3280088D1 (de) 1990-02-22
IL66566A0 (en) 1982-12-31
AU8742282A (en) 1983-02-24

Similar Documents

Publication Publication Date Title
BG40142A3 (en) Method for preparing piperazine derivatives
IL77133A (en) Antineoplastic pharmaceutical compositions containing pentofuranoside derivatives,some new such compounds and their preparation
GR3020976T3 (en) Ranolazine and related piperazines used in the treatment of tissues experiencing a physical or chemical insult
GB2163153B (en) New arylic derivatives of piperazine, the method of preparing same and their application in therapeutics
GB9024645D0 (en) Measurement of carbon in ash
ZA845538B (en) Anthracyclin derivatives,a process for their preparation and their use as cytostatic agents
DE3362189D1 (en) 14-amino-steroid derivatives, process for their preparation and their use in therapy
HK47592A (en) Piperazine derivatives
Pybus Parelaphostrongylus andersoni Prestwood 1972 and P. odocoilei (Hobmaeir and Hobmaier 1934)(Nematoda: Metastrongyloidea) in two cervid definitive hosts
ZA864717B (en) Terguride as a geriatric agent
ZA818900B (en) 1,4-disubstituted piperazine derivatives and process for the preparation thereof
GB8922854D0 (en) Piperazine derivatives
Esnault et al. Dyson's Lemma for Polynominals in several variables
ES8603714A1 (es) Procedimiento para la preparacion de adinazolamo metanosulfonato cristalino, esencialmente no higroscopico
GB2134915B (en) Disazo compounds for use in dyeing
IL84192A0 (en) Hybrid plasmid for replication in methylotrophic microorganisms,and a process for its preparation
GB2165822B (en) Folding zone adjustment in sheet folding apparatus
CS152488A1 (en) Derivatives of 1-/10,11-dihydrodibenzo/b,f/thiepin-10-yl/piperazine,their hydrochloride and process for preparing them
IE830031L (en) Process for treating anestrunsin in ewes and cattle¹employing a gestogen followed by lh-rh
ZA927271B (en) Envelopes and blanks for making them.
IE901794L (en) Piperazine derivatives
PH23737A (en) Calcium antagonist piperazine derivatives,and compositions therefor
BG47253A1 (en) 1, 4- symmetrically di- substituted piperazine derivatives and method for their preparation
PL256280A2 (en) Versatile contour master in particular for machining shafts
IE881113L (en) Piperazine derivatives